View Larger Image
Vetoryl Caps 60 mg - 30 count
Item Number: R40151
✓ In Stock
• Free Ground Shipping
• Prescription Required
Please wait while we perform your request.
Promising new treatment for Cushing's Syndrome in dogs. Fewer & less severe side-effects reported than Mitotane. Competitive inhibitor of the enzyme 3-beta-hydroxysteroid dehydrogenase.
FDA-Approved enzyme-inhibiting drug for treatment of Cushing's Disease in dogs. Vetoryl (Trilostane) is a promising new medication indicated for use in pituitary-dependant hyperadrenocorticism (which comprises a majority of canine Cushing's Disease cases). Vetoryl is also the first medication to receive Minor Use designation for treatment of Cushing's caused by adrenal tumors.
About Cushing's Disease
The affected animal has a characteristic presentation including increased water consumption and resulting increased urination, increased appetite, hair loss, and a potbellied appearance. There are several diagnostic tests available, as well as several treatments.
Lupron Depot for Ferret Adrenal Disease
These products may also interest you...